← All news

FROM THE NEWS FEED

Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment

2026-09-09 β€’ Psychedelic Invest

Article summary

NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- via BioMedWire β€” Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+…

Continue to the original publication for the complete article.